- Home
- LNTH vs COMM Comparison
LNTH vs COMM Comparison
Compare LNTH & COMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | COMM |
|---|---|---|
| Founded | 1956 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.8B |
| IPO Year | 2015 | 2013 |
Fundamental Metrics
Financial Performance| Metric | LNTH | COMM |
|---|---|---|
| Price | $66.12 | $19.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $77.33 | $13.25 |
| AVG Volume (30 Days) | 1.0M | ★ 4.7M |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.39 | ★ 3.52 |
| Revenue | $1,525,933,000.00 | ★ $5,299,100,000.00 |
| Revenue This Year | $0.01 | $37.00 |
| Revenue Next Year | $1.24 | $7.36 |
| P/E Ratio | $27.84 | ★ $14.69 |
| Revenue Growth | 1.95 | ★ 33.82 |
| 52 Week Low | $47.25 | $2.94 |
| 52 Week High | $111.29 | $20.55 |
Technical Indicators
Market Signals| Indicator | LNTH | COMM |
|---|---|---|
| Relative Strength Index (RSI) | 72.55 | 58.65 |
| Support Level | $60.15 | $18.51 |
| Resistance Level | $64.40 | $20.61 |
| Average True Range (ATR) | 2.09 | 0.79 |
| MACD | 0.66 | 0.03 |
| Stochastic Oscillator | 94.44 | 64.18 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center, and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center, and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services, and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. The company's operating segments are: Connectivity and Cable Solutions (CCS), Networking, Intelligent Cellular and Security Solutions (NICS), and Access Network Solutions (ANS).